[DIA Europe 2024] Impact of the New Pharma Legislation on Regulatory Operations

Logo
Presented by

Remco Munnik, Juan Garcia-Burgos, Vada A. Perkins, Paul-Etienne Schaeffer, Julie Spony, Elizabeth Scanlan

About this talk

Building on the DIAmond session on the topic of ‘The New Pharmaceutical Legislation’ - This session deep dives into its impact on Regulatory Operations; highlighting the role of automation and interoperability within regulatory affairs in Europe and how sector hopes to achieve regulatory efficiency from the process, data and technology point of view. The session is also complemented by a case study that deep dives into electronic product information to address what is perceived as missing both from a content and technical point of view.
Related topics:

More from this channel

Upcoming talks (0)
On-demand talks (55)
Subscribers (607)
The Drug Information Association (DIA) is a global and neutral association that mobilizes the life science community (regulators, industry, healthcare professionals, patients, payers, and students) to identify and tackle the most complex health challenges. DIA brings all these stakeholders together to find and discuss solutions, build a more robust and innovative healthcare ecosystem and, ultimately, improve patient outcomes worldwide. DIA executes its mission by fostering timely and critical conversations and networking sessions across many platforms, including conferences, workshops, DIA-led research projects, structured training, eLearning courses, digital content platforms, and publications, without corporate funding.